← FDA DRUG APPROVALS

FDA NDA · NDA218585

VIZZ

aceclidine

Sponsor: LENZ THERAP

APPLICATION
NDA218585
TYPE
NDA
ORIGINAL APPROVAL
2025-07-31
LATEST ACTION
2025-07-31
ROUTE
OPHTHALMIC
DOSAGE FORM
SOLUTION/DROPS
MARKETING STATUS
Prescription

Products

VIZZ · ReferencePrescription
ACECLIDINE HYDROCHLORIDE EQ 1.44% BASE · SOLUTION/DROPS · OPHTHALMIC

Approval history

2025-07-31Type 1 - New Molecular Entity · Original · standardLetterAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →